Eyelid papules and patchy alopecia in an 8 ‐month‐old boy

Pediatric Dermatology, Volume 35, Issue 6, Page 825-826, November/December 2018.
Source: Pediatric Dermatology - Category: Dermatology Authors: Tags: PHOTOQUIZ Source Type: research

Related Links:

Authors: Callender VD, Belpulsi D Abstract It is with great fervor that I revisit the article published in Journal of Drugs in Dermatology by Soleymani et al, titled “The Infatuation With Biotin Supplementation: Is There Truth Behind Its Rising Popularity? A Comparative Analysis of Clinical Efficacy versus Social Popularity.”1 First, I’d like to thank the authors for raising awareness of the overuse of biotin for hair loss and reminding us of the struggle we are faced with daily when debunking quick-fix myths propagated by media infatuation. PMID: 31524996 [PubMed - in process]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Source Type: research
British Journal of Cancer, Published online: 17 September 2019; doi:10.1038/s41416-019-0576-5Comment on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines”
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
British Journal of Cancer, Published online: 17 September 2019; doi:10.1038/s41416-019-0577-4Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.”
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Condition:   Female Pattern Hair Loss Interventions:   Drug: Topical minoxidil 5% in 90% ethanol and 5% propylene glycol;   Drug: Topical minoxidil 5% in pure ethanol alone;   Other: Placebo (Ethanol) Sponsor:   Sohag University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Using a mini organ model, scientists reveal how taxane chemotherapy can permanently damage hair follicles, and how a newer class of drug could prevent it.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Dermatology Source Type: news
Condition:   Female Pattern Hair Loss Interventions:   Drug: Topical minoxidil 5% in 90% ethanol and 5% propylene glycol;   Drug: Topical minoxidil 5% in pure ethanol alone;   Other: Placebo (Ethanol) Sponsor:   Sohag University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This study was designed to evaluate the clinical efficacy, recurrence rate, and safety of the new therapy with oral glycyrrhizin in adult patients with mild to moderate active AA.MethodsIt was a randomized controlled trial using two oral tablets of 25 mg glycyrrhizin three times per day (tid) for test group (65 patients), or two oral tablets of 25 mg cystine tid for the control (56 cases). Patients in both groups were also treated with topical 0.05% halometasone cream twice daily (bid). The treatment period was 24 weeks, including 12 weeks of active therapy, followed by another 12 weeks of observation.Results...
Source: European Journal of Integrative Medicine - Category: Complementary Medicine Source Type: research
In conclusion, although the two components influenced the β‐catenin signaling activity in distinct mechanisms, they both increased the viability of DP cells and promoted the cycle of hair follicles .
Source: BioFactors - Category: Biochemistry Authors: Tags: RESEARCH COMMUNICATION Source Type: research
by Na Liu, Yu Yin, Haiying Wang, Zhongcheng Zhou, Xiaoyan Sheng, Haifeng Fu, Renpeng Guo, Hua Wang, Jiao Yang, Peng Gong, Wen Ning, Zhenyu Ju, Yifei Liu, Lin Liu Telomere shortening is associated with aging and age-associated diseases. Additionally, telomere dysfunction resulting from telomerase gene mutation can lead to premature aging, such as apparent skin atrophy and hair loss. However, the molecular signaling linking telomere dysfunction to skin atrop hy remains elusive. Here we show that dysfunctional telomere disrupts BMP/pSmad/P63 signaling, impairing epidermal stem cell specification and differentiation of skin a...
Source: PLoS Genetics - Category: Genetics & Stem Cells Authors: Source Type: research
More News: Alopecia | Dermatology | Pediatrics | Skin